| Authors: |
Takahashi N; Department of Hematology, Nephrology, and Rheumatology, Akita University School of Medicine, Akita, Akita, Japan. naotot@doc.med.akita-u.ac.jp., Kikushige Y; Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Fukuoka, Japan., Nakamae H; Department of Hematology, Osaka Metropolitan University Hospital, Osaka, Osaka, Japan., Goto T; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Aichi, Japan., Tomita A; Department of Hematology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan., Ichii M; Department of Hematology and Oncology, Osaka University Hospital, Suita, Osaka, Japan., Ito S; Department of Hematology, Yamagata University Hospital, Yamagata, Yamagata, Japan., Teshima T; Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Hokkaido, Japan., Kirito K; Department of Hematology and Oncology, University of Yamanashi, Chuo, Yamanashi, Japan., Ikezoe T; Department of Hematology, Fukushima Medical University, Fukushima, Fukushima, Japan., Hatano K; Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan., Tanaka H; Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan., Hiramoto N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan., Osako R; Novartis Pharma K.K., Tokyo, Japan., Aoki M; Novartis Pharma K.K., Tokyo, Japan., Malek K; Novartis Pharma AG, Basel, Switzerland., Ueda Y; Department of Hematology/Oncology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan. |
